Compare IRTC & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | MTH |
|---|---|---|
| Founded | 2006 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.4B |
| IPO Year | 2016 | 1997 |
| Metric | IRTC | MTH |
|---|---|---|
| Price | $92.08 | $64.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $153.27 | $70.63 |
| AVG Volume (30 Days) | 882.0K | ★ 986.0K |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 2.96% |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ 3.22 |
| Revenue | ★ $747,138,000.00 | N/A |
| Revenue This Year | $19.54 | N/A |
| Revenue Next Year | $20.15 | $3.85 |
| P/E Ratio | ★ N/A | $20.16 |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $82.85 | $56.66 |
| 52 Week High | $192.47 | $85.38 |
| Indicator | IRTC | MTH |
|---|---|---|
| Relative Strength Index (RSI) | 35.32 | 48.54 |
| Support Level | N/A | $62.77 |
| Resistance Level | $125.16 | $66.79 |
| Average True Range (ATR) | 6.69 | 2.54 |
| MACD | -3.86 | -0.14 |
| Stochastic Oscillator | 16.68 | 25.65 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.